← Eichor
Condition: Human Immunodeficiency Virus Hiv Prophylaxis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human Immunodeficiency Virus Hiv Prophylaxis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
NA · 1 location(s) · University of Colorado, Denver · NCT06117163German Centre for Infection Research HIV Translational Platform
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT02149004HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Phase 4 · 6 location(s) · Cara Spence · NCT07160075Pre-exposure Prophylaxis (PrEP) for Health
NA · 2 location(s) · Brown University · NCT04430257HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
NA · 1 location(s) · University of Washington · NCT07089966Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06267508A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Phase 3 · 30 location(s) · Merck Sharp & Dohme LLC · NCT07071623Universal Test and Connect for HIV Service Delivery in South Africa
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06408142Vienna HIV Infection Via Sex Study
Phase N/A · 1 location(s) · Medical University of Vienna · NCT05326061A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · 81 location(s) · Merck Sharp & Dohme LLC · NCT07044297Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of
Phase 3 · 34 location(s) · ViiV Healthcare · NCT06134362ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
NA · 8 location(s) · Oswaldo Cruz Foundation · NCT07497594PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
NA · 2 location(s) · Boston Medical Center · NCT05769218Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care
NA · 1 location(s) · University of California, Los Angeles · NCT07495059
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.